Checkpoint inhibitor immunotherapy induced inflammatory arthritis secondary to Nivolumab and Ipilimumab: a pediatric first
Pediatr Rheumatol Online J. 2024 Apr 29;22(1):49. doi: 10.1186/s12969-024-00983-3. ABSTRACT BACKGROUND: Immune checkpoint inhibitors (ICIs) have expanded the arsenal of cancer therapeutics over the last …